Precigen, Inc.
PGEN
Rank in Stocks
#6535
Precigen, Inc. is an American company dedicated to the discovery and... Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC. Established in 1998, Precigen, Inc., previously known as Intrexon Corporation, adopted its current name in January 2020 and is headquartered in Germantown, Maryland.
Share Price
$4.73
Last synced: 2026-11-09
Market Cap
$1.69B
Change (1 day)
5.82%
Change (1 year)
19.44%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Precigen, Inc. (PGEN)
Category
Healthcare
Operating Margin for Precigen, Inc. (PGEN)
Operating Margin as of November 2026 TTM: -46.08%
According to Precigen, Inc.'s latest financial reports, its current operating margin (TTM) is -46.08%. At the end of 2025 the company had an operating margin of -1,100.78%.
Operating Margin history for Precigen, Inc. from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -46.08% | -95.81% |
| 2025 | -1,100.78% | -68.00% |
| 2024 | -3,440.23% | 114.67% |
| 2023 | -1,602.54% | 469.45% |
| 2022 | -281.42% | -56.33% |
| 2021 | -644.48% | 138.86% |
| 2020 | -269.81% | 0.00% |
| 2019 | -269.81% | -14.31% |
| 2018 | -314.88% | 427.44% |
| 2017 | -59.70% | -8.94% |
| 2016 | -65.56% | -22.51% |
| 2015 | -84.60% | -13.02% |
| 2014 | -97.26% | -60.17% |
| 2013 | -244.20% | -54.76% |
| 2012 | -539.73% | -47.53% |
| 2011 | -1,028.67% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.84% |
US
|
|
| -149.01% | -96.77% |
US
|
|
| 25.57% | -100.55% |
AU
|
|
| 31.23% | -100.68% |
BE
|
|
| 29.35% | -100.64% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Precigen, Inc.'s operating margin
What is Precigen, Inc.'s operating margin?
Precigen, Inc.'s operating margin is -46.08%, as of Nov 2026.
What was Precigen, Inc.'s operating margin in 2025?
In 2025, Precigen, Inc.'s operating margin was -1,100.78%, compared with -3,440.23% in 2024.
How has Precigen, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Precigen, Inc.'s operating margin was highest in 2020 (-269.81%) and lowest in 2024 (-3,440.23%).
How does Precigen, Inc.'s operating margin compare with similar companies?
Precigen, Inc.'s operating margin (-46.08%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.